Lobeline Effects on Cognitive Performance in Adult ADHD

Objective: In preclinical studies, lobeline inhibited hyperactivity induced by nicotine and amphetamine, and improved performance and learning in studies utilizing radial-arm maze and spatial-discrimination water maze. This laboratory proof-of-concept study investigated lobeline as a treatment for A...

Full description

Bibliographic Details
Main Authors: Dwoskin, L.P (Author), Guenthner, G. (Author), Kleven, M.S (Author), Martin, C.A (Author), Nuzzo, P.A (Author), Ranseen, J.D (Author), Walsh, S.L (Author), Williams, Y. (Author)
Format: Article
Language:English
Published: SAGE Publications Inc. 2018
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02713nam a2200649Ia 4500
001 10.1177-1087054713497791
008 220706s2018 CNT 000 0 und d
020 |a 10870547 (ISSN) 
245 1 0 |a Lobeline Effects on Cognitive Performance in Adult ADHD 
260 0 |b SAGE Publications Inc.  |c 2018 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1177/1087054713497791 
520 3 |a Objective: In preclinical studies, lobeline inhibited hyperactivity induced by nicotine and amphetamine, and improved performance and learning in studies utilizing radial-arm maze and spatial-discrimination water maze. This laboratory proof-of-concept study investigated lobeline as a treatment for ADHD symptoms in adults (31.11 ± 7.08 years). Method: Using cognitive tasks and self-report measures, the effects of lobeline (0, 7.5, 15, or 30 mg, s.l.) and methylphenidate (0, 15, or 30 mg, p.o.) were assessed in nine volunteers with ADHD. Results: Evidence suggested that lobeline could modestly improve working memory in adults with ADHD, but no significant improvement in attention was observed. Lobeline administration was associated with mild adverse side effects (nausea). Conclusion: Further investigation of lobeline on working memory may be warranted. © The Author(s) 2013. 
650 0 4 |a ADHD 
650 0 4 |a adult 
650 0 4 |a Adult 
650 0 4 |a attention 
650 0 4 |a Attention 
650 0 4 |a attention deficit disorder 
650 0 4 |a Attention Deficit Disorder with Hyperactivity 
650 0 4 |a Central Nervous System Stimulants 
650 0 4 |a central stimulant agent 
650 0 4 |a cognition 
650 0 4 |a Cognition 
650 0 4 |a dose response 
650 0 4 |a Dose-Response Relationship, Drug 
650 0 4 |a double blind procedure 
650 0 4 |a Double-Blind Method 
650 0 4 |a drug effect 
650 0 4 |a female 
650 0 4 |a Female 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a Impulsive Behavior 
650 0 4 |a impulsiveness 
650 0 4 |a lobeline 
650 0 4 |a Lobeline 
650 0 4 |a male 
650 0 4 |a Male 
650 0 4 |a Memory, Short-Term 
650 0 4 |a methylphenidate 
650 0 4 |a Methylphenidate 
650 0 4 |a nicotinic agent 
650 0 4 |a Nicotinic Agonists 
650 0 4 |a physiology 
650 0 4 |a psychology 
650 0 4 |a short term memory 
650 0 4 |a treatment outcome 
650 0 4 |a Treatment Outcome 
700 1 |a Dwoskin, L.P.  |e author 
700 1 |a Guenthner, G.  |e author 
700 1 |a Kleven, M.S.  |e author 
700 1 |a Martin, C.A.  |e author 
700 1 |a Nuzzo, P.A.  |e author 
700 1 |a Ranseen, J.D.  |e author 
700 1 |a Walsh, S.L.  |e author 
700 1 |a Williams, Y.  |e author 
773 |t Journal of Attention Disorders